{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:54:17Z","timestamp":1771001657038,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,3,19]],"date-time":"2008-03-19T00:00:00Z","timestamp":1205884800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s10928-008-9084-6","type":"journal-article","created":{"date-parts":[[2008,3,18]],"date-time":"2008-03-18T16:41:49Z","timestamp":1205858509000},"page":"203-217","source":"Crossref","is-referenced-by-count":35,"title":["A model based assessment of the CYP2B6 and CYP2C19 inductive properties by artemisinin antimalarials: implications for combination regimens"],"prefix":"10.1007","volume":"35","author":[{"given":"Doaa A.","family":"Elsherbiny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Asimus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats O.","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrika S. H.","family":"Simonsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,19]]},"reference":[{"issue":"8","key":"9084_CR1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI21682","volume":"113","author":"NJ White","year":"2004","unstructured":"White NJ (2004). Antimalarial drug resistance. J Clin Invest 113(8): 1084\u20131092","journal-title":"J Clin Invest"},{"issue":"4","key":"9084_CR2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2165\/00003088-200039040-00002","volume":"39","author":"V Navaratnam","year":"2000","unstructured":"Navaratnam V, Mansor SM, Sit NW, Grace J, Li Q and Olliaro P (2000). Pharmacokinetics of artemisinin-type compounds. Clin Pharmacokinet 39(4): 255\u2013270","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"9084_CR3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0009-9236(98)90149-7","volume":"64","author":"US Svensson","year":"1998","unstructured":"Svensson US, Ashton M, Trinh NH, Bertilsson L, Dinh XH and Nguyen VH et al (1998). Artemisinin induces omeprazole metabolism in human beings. Clin Pharmacol Ther 64(2): 160\u2013167","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"9084_CR4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1472-8206.1999.tb00379.x","volume":"13","author":"K Mihara","year":"1999","unstructured":"Mihara K, Svensson US, Tybring G, Hai TN, Bertilsson L and Ashton M (1999). Stereospecific analysis of omeprazole supports artemisinin as a potent inducer of CYP2C19. Fundam Clin Pharmacol 13(6): 671\u2013675","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"9084_CR5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0009-9236(03)00092-4","volume":"74","author":"US Simonsson","year":"2003","unstructured":"Simonsson US, Jansson B, Hai TN, Huong DX, Tybring G and Ashton M (2003). Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9. Clin Pharmacol Ther 74(1): 32\u201343","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"9084_CR6","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1124\/mol.104.009019","volume":"67","author":"O Burk","year":"2005","unstructured":"Burk O, Arnold KA, Nussler AK, Schaeffeler E, Efimova E and Avery BA et al (2005). Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol 67(6): 1954\u20131965","journal-title":"Mol Pharmacol"},{"issue":"3","key":"9084_CR7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1472-8206.2007.00471.x","volume":"21","author":"S Asimus","year":"2007","unstructured":"Asimus S, Elsherbiny D, Hai TN, Jansson B, Huong NV and Petzold MG et al(2007). Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects. Fundam Clin Pharmacol 21(3): 307\u2013316","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"9084_CR8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0035-9203(96)90480-0","volume":"90","author":"M Hassan Alin","year":"1996","unstructured":"Hassan Alin M, Ashton M, Kihamia CM, Mtey GJ and Bjorkman A (1996). Multiple dose pharmacokinetics of oral artemisinin and comparison of its efficacy with that of oral artesunate in falciparum malaria patients. Trans R Soc Trop Med Hyg 90(1): 61\u201365","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"9084_CR9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0009-9236(98)90044-3","volume":"63","author":"M Ashton","year":"1998","unstructured":"Ashton M, Nguyen DS, Nguyen VH, Gordi T, Trinh NH and Dinh XH et al (1998). Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria. Clin Pharmacol Ther 63(4): 482\u2013493","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"9084_CR10","first-page":"25","volume":"26","author":"M Ashton","year":"1998","unstructured":"Ashton M, Hai TN, Sy ND, Van Huong DX, Nieu NT and Huong N et al (1998). Artemisinin pharmacokinetics is time-dependent during repeated oral administration in healthy male adults. Drug Metab Dispos 26(1): 25\u201327","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"9084_CR11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s002280050658","volume":"55","author":"M Vugt van","year":"1999","unstructured":"van Vugt M, Edstein MD, Proux S, Lay K, Ooh M, Looareesuwan S and Vugt M et al (1999). Absence of an interaction between artesunate and atovaquone\u2013proguanil. Eur J Clin Pharmacol 55(6): 469\u2013474","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"9084_CR12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00003088-200140050-00003","volume":"40","author":"PT Giao","year":"2001","unstructured":"Giao PT, Vries PJde (2001). Pharmacokinetic interactions of antimalarial agents. Clin Pharmacokinet 40(5): 343\u2013373","journal-title":"Clin Pharmacokinet"},{"key":"9084_CR13","unstructured":"WHO. Facts on ACTs (Artemisinin-based Combination Therapies). 2006 [cited 7 December 2007; Available from: http:\/\/www.rbm.who.int\/cmc_upload\/0\/000\/015\/364\/RBMInfosheet_9.htm"},{"issue":"4","key":"9084_CR14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0009-9236(97)90114-4","volume":"62","author":"RF Frye","year":"1997","unstructured":"Frye RF, Matzke GR, Adedoyin A, Porter JA and Branch RA (1997). Validation of the five-drug \u201cPittsburgh cocktail\u201d approach for assessment of selective regulation of drug-metabolizing enzymes. Clin Pharmacol Ther 62(4): 365\u2013376","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"9084_CR15","first-page":"662","volume":"234","author":"PJ Wedlund","year":"1985","unstructured":"Wedlund PJ, Aslanian WS, Jacqz E, McAllister CB, Branch RA and Wilkinson GR (1985). Phenotypic differences in mephenytoin pharmacokinetics in normal subjects. J Pharmacol Exper Ther 234(3): 662\u2013669","journal-title":"J Pharmacol Exper Ther"},{"issue":"Pt 6","key":"9084_CR16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/000456329903600604","volume":"36","author":"J Weide van der","year":"1999","unstructured":"van der Weide J, Steijns LS (1999). Cytochrome P450 enzyme system: genetic polymorphisms and impact on clinical pharmacology. Ann Clin Biochem 36(Pt 6): 722\u2013729","journal-title":"Ann Clin Biochem"},{"issue":"8","key":"9084_CR17","first-page":"775","volume":"26","author":"JW Ko","year":"1998","unstructured":"Ko JW, Desta Z and Flockhart DA (1998). Human N-demethylation of (S)-mephenytoin by cytochrome P450s 2C9 and 2B6. Drug Metab Dis 26(8): 775\u2013778","journal-title":"Drug Metab Dis"},{"issue":"1","key":"9084_CR18","first-page":"28","volume":"230","author":"A Kupfer","year":"1984","unstructured":"Kupfer A, Patwardhan R, Ward S, Schenker S, Preisig R and Branch RA (1984). Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans. J Pharmacol Exper Ther 230(1): 28\u201333","journal-title":"J Pharmacol Exper Ther"},{"issue":"3","key":"9084_CR19","first-page":"590","volume":"221","author":"A Kupfer","year":"1982","unstructured":"Kupfer A, Desmond PV, Schenker S and Branch RA (1982). Stereoselective metabolism and disposition of the enantiomers of mephenytoin during chronic oral administration of the racemic drug in man. J Pharmacol Exper Ther 221(3): 590\u2013597","journal-title":"J Pharmacol Exper Ther"},{"key":"9084_CR20","unstructured":"Beal SL, Sheiner LS. NONMEM user\u2019s guides, GloboMax Inc., Hanover, Maryland, 1989\u20141998"},{"issue":"1","key":"9084_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","volume":"58","author":"EN Jonsson","year":"1999","unstructured":"Jonsson EN and Karlsson MO (1999). Xpose\u2013an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed 58(1): 51\u201364","journal-title":"Comput Methods Programs Biomed"},{"issue":"6","key":"9084_CR22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/clpt.1986.113","volume":"39","author":"E Jacqz","year":"1986","unstructured":"Jacqz E, Hall SD, Branch RA and Wilkinson GR (1986). Polymorphic metabolism of mephenytoin in man: pharmacokinetic interaction with a co-regulated substrate, mephobarbital. Clin Phar Ther 39(6): 646\u2013653","journal-title":"Clin Phar Ther"},{"issue":"6","key":"9084_CR23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-2125.2003.01967.x","volume":"56","author":"T Kerbusch","year":"2003","unstructured":"Kerbusch T, Wahlby U, Milligan PA and Karlsson MO (2003). Population pharmacokinetic modelling of darifenacin and its hydroxylated metabolite using pooled data, incorporating saturable first-pass metabolism, CYP2D6 genotype and formulation-dependent bioavailability. Br J Clin Pharmacol 56(6): 639\u2013652","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"9084_CR24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2125.1999.00090.x","volume":"48","author":"M Hassan","year":"1999","unstructured":"Hassan M, Svensson US, Ljungman P, Bjorkstrand B, Olsson H and Bielenstein M et al (1999). A mechanism-based pharmacokinetic-enzyme model for cyclophosphamide autoinduction in breast cancer patients. Br J Clin Pharmacol 48(5): 669\u2013677","journal-title":"Br J Clin Pharmacol"},{"key":"9084_CR25","unstructured":"Holford N (2005) The Visual predictive check\u2014superiority to standard diagnostic (Rorschach) Plots. Available from: http:\/\/www.page-meetingorg\/?abstract=738 . [cited PAGE 14; Abstr 738]"},{"issue":"6","key":"9084_CR26","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2125.2006.02844.x","volume":"63","author":"S Asimus","year":"2007","unstructured":"Asimus S and Gordi T (2007). Retrospective analysis of artemisinin pharmacokinetics: application of a semiphysiological autoinduction model. Br J Clin Pharmacol 63(6): 758\u2013762","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"9084_CR27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00008571-199512000-00004","volume":"5","author":"M Chang","year":"1995","unstructured":"Chang M, Dahl ML, Tybring G, Gotharson E and Bertilsson L (1995). Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype. Pharmacogenetics 5(6): 358\u2013363","journal-title":"Pharmacogenetics"},{"issue":"3","key":"9084_CR28","first-page":"493","volume":"203","author":"A Kupfer","year":"1977","unstructured":"Kupfer A, Bircher J and Preisig R (1977). Stereoselective metabolism, pharmacokinetics and biliary elimination of phenylethylhydantoin (Nirvanol) in the dog. J Pharmacol Exper Ther 203(3): 493\u2013499","journal-title":"J Pharmacol Exper Ther"},{"issue":"10","key":"9084_CR29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003088-200241100-00005","volume":"41","author":"MS Roberts","year":"2001","unstructured":"Roberts MS, Magnusson BM, Burczynski FJ and Weiss M (2001). Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet 41(10): 751\u2013790","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-008-9084-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10928-008-9084-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-008-9084-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T08:56:41Z","timestamp":1559465801000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10928-008-9084-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,19]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["9084"],"URL":"https:\/\/doi.org\/10.1007\/s10928-008-9084-6","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,19]]}}}